PNPO antibody
-
- Target See all PNPO Antibodies
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This PNPO antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)
- Characteristics
- Homo sapiens pyridoxamine 5'-phosphate oxidase (PNPO)
- Purification
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human PNPO(NP_060599) produced in HEK293T cell.
- Clone
- 1G9
- Isotype
- IgG2a
- Top Product
- Discover our top product PNPO Primary Antibody
-
-
- Application Notes
- WB 1:4000, IHC 1:150, FLOW 1:100,
- Comment
-
The concentration of the product may vary between diferrent lots.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5-1.0 mg/mL
- Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
-
- Target
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
- Alternative Name
- PNPO (PNPO Products)
- Background
- The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. COMPLETENESS: complete on the 3' end.
- Molecular Weight
- 29.8 kDa
- Gene ID
- 55163
- NCBI Accession
- NM_018129
- HGNC
- 55163
-